Vaccines

29 Sep 2020 Altimmune Presents Highlights of Intranasal COVID-19 Vaccine and Therapeutic Programs – AdCOVID™ and T-COVID™ – at the World Vaccine Congress
29 Sep 2020 Imvaq Therapeutics Raises $15 Million in Series B Financing to Fund IND and Phase 1 Trials
28 Sep 2020 COVAXX Initiates Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 in Taiwan
28 Sep 2020 INOVIO reports FDA partial clinical hold for planned Phase 2 / 3 trial of COVID-19 vaccine candidate INO-4800
25 Sep 2020 ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre-Clinical Trials
25 Sep 2020 Advaxis Announces FDA Clearance of New IND for ADXS-504 for Treatment of Prostate Cancer
25 Sep 2020 Anokion Announces FDA Clearance of IND Application for ANK-700 for the Treatment of Multiple Sclerosis
25 Sep 2020 Clover Biopharmaceuticals Announces Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine Candidate
25 Sep 2020 Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom
23 Sep 2020 Sinovac’s Coronavac™, SARS-CoV-2 Vaccine (Vero Cell), Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children
23 Sep 2020 Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate
23 Sep 2020 St. Louis-based Precision Virologics and India's Biotech leader Bharat Biotech obtain rights to intranasal COVID-19 vaccine technology
21 Sep 2020 OSE Immunotherapeutics Presents Positive Step-1 Phase 3 Results for Tedopi® in NSCLC at the European Society for Medical Oncology Virtual Congress 2020
18 Sep 2020 Ufovax Announces Its Self-Assembling NanoParticles as the Next-Generation Vaccine Solution for COVID-19
16 Sep 2020 Curevo Vaccine Announces Robust Antibody Response Results of Phase I Clinical Trial of Investigational Vaccine for Shingles CRV-101
14 Sep 2020 Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
13 Sep 2020 Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial
12 Sep 2020 COVID-19 vaccine AZD1222 clinical trials resumed in the UK
10 Sep 2020 Axon Announces Positive Pre-Clinical Results for its Peptide Vaccine (ACvac1) Against Novel Coronavirus
10 Sep 2020 Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-based Vaccine Candidate Against COVID-19
10 Sep 2020 Sinovac Reports Preliminary Phase I/II Results of COVID-19 Vaccine in Elderly Volunteers
10 Sep 2020 Statement on AstraZeneca Oxford SARS-CoV-2 vaccine, AZD1222, COVID-19 vaccine trials temporary pause
09 Sep 2020 Merck Announces Positive Topline Results from Two Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine, Including Pivotal Trial
09 Sep 2020 Enterome - First Patient Dosed in a Phase 1/2 Trial with EO2401, an Innovative 'OncoMimic' based Immunotherapy Candidate Targeting Adrenal Tumors
09 Sep 2020 Eveliqure announces the award of a NIAID contract to finance Phase 2 clinical studies of its combined Shigella and ETEC vaccine candidate

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top